The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study

This publication has 30 references indexed in Scilit:

• Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas
  Radiotherapy and Oncology, 2004
• Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results
  Radiotherapy and Oncology, 2004
• Evaluation of quality of life of patients with oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study
  Radiotherapy and Oncology, 2004
• Impact of EGFR expression on the response of advanced head and neck carcinomas to concomitant boost radiotherapy in a RTOG phase III trial (90-03)
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Acute and late normal tissue reactions in the DAHANCA 6&7 randomized trial with accelerated radiotherapy for head and neck cancer
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Co‐localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma
  The Journal of Pathology, 2001
• Very accelerated versus conventional radiotherapy in HNSCC: Results of the GORTEC 94-02 randomized trial
  International Journal of Radiation Oncology*Biology*Physics, 2000
• Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro.
  Journal of Clinical Investigation, 1998
• Standardization of Immunohistochemistry Based on Antigen Retrieval Technique for Routine Formalin-fixed Tissue Sections
  Applied Immunohistochemistry & Molecular Morphology, 1998
• Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation
  Oncogene, 1997